Cleveland

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer2 trials
• Endometrial cancer1 trial
• Ovarian cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 1/22 trials

Status

• Recruiting2 trials

Lead sponsor

• Avenzo Therapeutics, Inc.2 trials

Running trials

• Recruiting

  ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

  NCT06998407· Phase 1/2· Avenzo Therapeutics, Inc.· Source

  Contact: Avenzo Therapeutics

• Recruiting

  Study of AVZO-021 in Patients With Advanced Solid Tumors

  NCT05867251· Phase 1/2· Avenzo Therapeutics, Inc.· Source

  Contact: Avenzo Therapeutics

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer2 recruiting
• Endometrial cancer1 recruiting
• Ovarian cancer1 recruiting
• Triple-negative breast cancer1 recruiting